Stock CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Corbus Pharmaceuticals Holdings, Inc.

Equities

CRBP

US21833P3010

Real-time Estimate Cboe BZX
Other stock markets
 14:59:43 10/05/2024 BST 		5-day change 1st Jan Change
42.95 USD -1.81% Intraday chart for Corbus Pharmaceuticals Holdings, Inc. +13.17% +626.41%
05-08 Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating MT
05-07 Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Corbus Pharmaceuticals Holdings, Inc. Appoints Dominic Smethurst as Chief Medical Officer
CI
Corbus Pharmaceuticals Holdings, Inc. Announces Resignation of Rachael Brake, Ph.D., as Chief Scientific Officer, Effective from February 19, 2024
CI
HLS Therapeutics Announcing CEO Transition; Craig Millian to Replace Retiring CEO, Gilbert Godin, on May 1, 2023
MT
Corbus Pharmaceuticals Holdings, Inc. Appoints Yong Ben to Its Board of Directors
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints Anne Altmeyer to Board of Directors
CI
Corbus Pharmaceuticals Appoints Rachael Brake as Chief Scientific Officer
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints Craig million as Chief Operating Officer
CI
Corbus Pharmaceuticals Holdings, Inc Announces Resignation of Barbara White as Chief Medical Officer
CI
Corbus Pharmaceuticals Holdings, Inc. Announces Resignation of Barbara White as Chief Medical Officer and Head of Research
CI
Corbus Pharmaceuticals Holdings, Inc. Announces the Resignation of Robert Discordia as Chief Operating Officer
CI
Robert Discordia Will No Longer Serve as Chief Operating Officer of Corbus Pharmaceuticals Holdings, Inc
CI
Corbus Pharmaceuticals Holdings, Inc Announces Resignation of David Hochman from the Board of Directors
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints George S. Golumbeski to its Board of Directors
CI
Corbus Pharmaceuticals Holdings, Inc. Announces Changes to its Board of Directors
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints Rachelle Jacques to Serve as A Member of the Board
CI
Corbus Pharmaceuticals Holdings, Inc. Announces Separation Agreement with Mark A. Tepper, President and Chief Scientific Officer
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints Craig million as Chief Commercial Officer
CI
Corbus Pharmaceuticals Appoints John K. Jenkins, Md to Board of Directors
CI
Corbus Pharmaceuticals Holdings, Inc. Announces Executives Appointments
CI
Corbus Pharmaceuticals Holdings, Inc. Appoints Paris Panayiotopoulos as Board of Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRBP Stock
  4. News Corbus Pharmaceuticals Holdings, Inc.
  5. Insiders